Cryoport and Kryosphere Form Strategic Marketing Alliance
September 13 2012 - 8:00AM
Business Wire
Cryoport, Inc. (OTCBB: CYRX) today announced it has formed a
strategic partnership with Kryosphere, a leading biorepository
serving clients throughout North America and internationally.
Cryoport and Kryosphere will introduce each other’s capabilities
and expertise in Cold Chain Logistics and Management of
biomaterials to their customers with a dedicated marketing
strategy.
“This collaborative opportunity will help unite a ‘critical
link’ in global Cold Chain Logistics and Biobanking for the life
science community,” said A. Neil Jones, Vice President of
Kryosphere.
Cryoport’s Chairman Stephen Wasserman stated, “Globalization of
the life science and healthcare industries is driving increased
demand for high quality frozen shipping and repository services. It
is a natural fit for two industry leaders like Cryoport and
Kryosphere to cooperate in providing the absolute best solutions
for our respective customers. We look forward to working with the
strong team at Kryosphere to make this alliance a success.”
About Kryosphere, Inc.
As a leading full-service Biomaterial Management Organization,
Kryosphere combines the latest technology and scientific expertise
in Biospecimen Sample Management, Clinical Trial Support and Cold
Chain of Custody Logistics. Kryosphere is a GLP/GMP Regulatory
compliant company focused on the management of biomaterials ranging
from controlled ambient temperature through LN2. Headquartered in
the Research Triangle Park of North Carolina with global
operations, Kryosphere consistently delivers high quality
collaborative support by providing critical resources that will
help assure/ensure the integrity of research as well as the future
of drug discovery and personalized medicine. For more information
about Kryosphere visit: www.kryosphere.com.
About Cryoport, Inc.
Cryoport provides leading edge cold chain logistics services
through the combination of purpose built proprietary technologies
and total turnkey management of the entire process. The Cryoport
Express® liquid nitrogen dry vapor shipper is validated to maintain
a constant -150°C temperature for a 10 plus day dynamic shipment
duration, and its Cryoportal™ Logistics Management Platform manages
the entire shipment process, including initial order, document
preparation, customs clearance, courier management, shipment
tracking, issue resolution, and delivery. Cryoport’s total turnkey
service management approach offers reliability, cost effectiveness,
and convenience, while the use of recyclable and reusable
components provides a “green” and environmentally friendly
solution. For more information visit www.cryoport.com.
Forward Looking Statements
Statements in this press release which are not purely
historical, including statements regarding Cryoport, Inc.’s
intentions, hopes, beliefs, expectations, representations,
projections, plans or predictions of the future are forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. It is important to note that the company's
actual results could differ materially from those in any such
forward-looking statements. Factors that could cause actual results
to differ materially include, but are not limited to, risks and
uncertainties associated with the effect of changing economic
conditions, trends in the products markets, variations in the
company's cash flow, market acceptance risks, and technical
development risks. The company’s business could be affected by a
number of other factors, including the risk factors listed from
time to time in the company's SEC reports including, but not
limited to, the annual report on Form 10-K for the year ended March
31, 2012. The company cautions investors not to place undue
reliance on the forward-looking statements contained in this press
release. Cryoport, Inc. disclaims any obligation, and does not
undertake to update or revise any forward-looking statements in
this press release.